Story perspectives

Weight Loss Drugs Linked to Sudden Blindness Risk

8/27/2025

41 8

Summary

Story summary

Patients report sudden, irreversible blindness linked to weight loss drugs like Ozempic, as experienced by Todd Engel from Maryland.
Engel's family urges clearer warnings about the risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) associated with these medications.
Research suggests an increased risk of NAION in semaglutide users, prompting demands for updated safety information.
Novo Nordisk asserts that NAION is rare and disputes connections between the drug and blindness.

1 of 1

Story summary

Patients report sudden, irreversible blindness linked to weight loss drugs like Ozempic, as experienced by Todd Engel from Maryland.
Engel's family urges clearer warnings about the risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) associated with these medications.
Research suggests an increased risk of NAION in semaglutide users, prompting demands for updated safety information.
Novo Nordisk asserts that NAION is rare and disputes connections between the drug and blindness.